CVE-2026-57495AgenticMail gives AI agents real email addresses and phone numbers.

AgenticMail gives AI agents real email addresses and phone numbers. In @agenticmail/claudecode prior to version 0.2.39, @agenticmail/codex prior to version 0.1.33, @agenticmail/core prior to version 0.9.43, and @agenticmail/openclaw prior to version 0.5.71, two inbound-mail handlers act on a privileged effect without verifying that the sender is the operator, while a sibling handler in the same repo does. The higher-impact one: any external email routed to the bridge inbox causes the dispatcher to resume the operator's Claude Code session with `permissionMode: 'bypassPermissions'`, embedding the attacker-controlled `from`/`subject`/`preview` verbatim into the prompt the resumed agent reads — an indirect prompt injection into a fully-privileged agent (Bash/Write/Edit/WebFetch + the agenticmail MCP toolbelt) running as the operator's OAuth identity. The sibling operator-query email-reply hook gates the same untrusted-From provenance with `isOperatorReplySender(replyFrom, config.operatorEmail)` (fail-closed); the bridge-wake path — a strictly higher-privilege effect — has no equivalent. @agenticmail/claudecode 0.2.39, @agenticmail/codex 0.1.33, @agenticmail/core 0.9.43, and @agenticmail/openclaw 0.5.71 contain a fix.

CVSS

8.2 HIGH (v4.0, NVD)CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Weakness (CWE)

CWE-306

Known exploited

Not in CISA's KEV catalog

EPSS (exploitation in the next 30 days)

Not loaded for this CVE

Assigned by

Not given

NVD analysis

Deferred

Record last updated

Jul 23, 2026

First seen by InfoSec Signals

Oct 9, 2026

The CVE record on cve.org · NVD's entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.